Evidence map›Paper›PMID 27960153›Full record

ArticleCellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology2016

CFTR Controls the Activity of NF-κB by Enhancing the Degradation of TRADD.

Hua Wang, Liudmila Cebotaru, Ha Won Lee, QingFeng Yang, Bette S Pollard, Harvey B Pollard, William B Guggino

Open access · goldAbstract read
In one paragraph

Article in Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Genetic and chemical correction of cystic fibrosis reduces airway susceptibility to SARS-CoV-2.American journal of physiology. Lung cellular and molecular physiology · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. CFTR and Gastrointestinal Cancers: An Update.Journal of personalized medicine · 2022
    Review
  11. Article
  12. Review
  13. Role of Mitochondria in Viral Infections.Life (Basel, Switzerland) · 2021
    Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Vasculitis in Cystic Fibrosis.Frontiers in pediatrics · 2020
    Review
  20. Autophagy, Unfolded Protein Response and Lung Disease.Current research in cell biology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Hua WangDepartment of Physiology, Medicine, School of Medicine, The Johns Hopkins University, Baltimore, USA.
Liudmila Cebotaru
Ha Won Lee
QingFeng Yang
Bette S Pollard
Harvey B Pollard
William B Guggino
Czech Academy of Sciences, Institute of Physiology · CZUniformed Services University of the Health Sciences · USJohns Hopkins University · USUnited States Equal Employment Opportunity Commission · US

Funding

CF Gene Therapy with adeno-associated viral vectorsR01HL122267 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI CEBOTARU, LIUDMILA, GUGGINO, WILLIAM B. · 2016 to 2020
$3.4M
NHLBI NIH HHS R01 HL122267
6 · The paper itself

Abstract

BACKGROUND/

aimsChronic lung infection in cystic fibrosis leads to an inflammatory response that persists because of the chronic presence of bacteria and ultimately leads to a catastrophic failure of lung function.

methodsWe use a combination of biochemistry, cell and molecular biology to study the interaction of TRADD, a key adaptor molecule in TNFα signaling, with CFTR in the regulation of NFκB.

resultsWe show that Wt CFTR binds to and colocalizes with TRADD. TRADD is a key signaling intermediate connecting TNFα with activation of NFκB. By contrast, ΔF508 CFTR does not bind to TRADD. NF-κB activation is higher in CFBE expressing ΔF508 CFTR than in cells expressing Wt CFTR. However, this differential effect is abolished when TRADD levels are knocked down. Transfecting Wt CFTR into CFBE cells reduces NF-κB activity. However the reduction is abolished by the CFTR chloride transport inhibitor-172. Consistently, transfecting in the correctly trafficked CFTR conduction mutants G551D or S341A also fail to reduce NFκB activity. Thus CFTR must be functional if it is to regulate NF-κB activity. We also found that TNFα produced a greater increase in NF-κB activity in CFBE cells than in the same cell when Wt CFTR-corrected. Consistently, the effect is also abolished when TRADD is knocked down by shRNA. Thus, Wt CFTR control of TRADD modulates the physiological activation of NF-κB by TNFα. Based on studies with proteosomal and lysosomal inhibitors, the mechanism by which Wt CFTR, but not ΔF508 CFTR, suppresses TRADD is by lysosomal degradation.

conclusionWe have uncovered a novel mechanism whereby Wt CFTR regulates TNFα signaling by enhancing TRADD degradation. Thus by reducing the levels of TRADD, Wt CFTR suppresses downstream proinflammatory NFκB signaling. By contrast, suppression of NF-κB activation fails in CF cells expressing ΔF508 CFTR.

Indexed as

ProteolysisAdaptor Proteins, Signal TransducingCarrier ProteinsCell LineCell MovementCystic Fibrosis Transmembrane Conductance RegulatorGolgi Matrix ProteinsHEK293 CellsHumansMembrane ProteinsMembrane Transport ProteinsNF-kappa BProtein BindingTime FactorsTNF Receptor-Associated Death Domain ProteinTumor Necrosis Factor-alphaAdaptor Proteins, Signal TransducingCarrier ProteinsCystic Fibrosis Transmembrane Conductance Regulatorcystic fibrosis transmembrane conductance regulator delta F508Golgi Matrix ProteinsGOPC protein, humanMembrane ProteinsMembrane Transport ProteinsNF-kappa BTNF Receptor-Associated Death Domain ProteinTumor Necrosis Factor-alpha

Identifiers

PMID27960153
PMCPMC7067292
OpenAlexW2567555475

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.